| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclase activity | 3.81e-11 | 24 | 109 | 7 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 5.27e-11 | 25 | 109 | 7 | GO:0016849 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 4.05e-10 | 18 | 109 | 6 | GO:0004016 | |
| GeneOntologyMolecularFunction | synaptic receptor adaptor activity | 6.30e-07 | 4 | 109 | 3 | GO:0030160 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.57e-06 | 5 | 109 | 3 | GO:0008294 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.19e-05 | 93 | 109 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 2.53e-05 | 11 | 109 | 3 | GO:0098919 | |
| GeneOntologyMolecularFunction | xylose binding | 2.95e-05 | 2 | 109 | 2 | GO:0033222 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 4.35e-05 | 13 | 109 | 3 | GO:0098879 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.62e-05 | 118 | 109 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.52e-04 | 441 | 109 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | lyase activity | 1.64e-04 | 212 | 109 | 7 | GO:0016829 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 1.86e-04 | 52 | 109 | 4 | GO:0035255 | |
| GeneOntologyMolecularFunction | galactose transmembrane transporter activity | 4.37e-04 | 6 | 109 | 2 | GO:0005354 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B DNAH10 CLPX PFN2 NUBPL HELQ KIFC2 DDX1 ATP12A KIF13A DDX28 | 5.34e-04 | 614 | 109 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.84e-04 | 70 | 109 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 6.99e-04 | 32 | 109 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | dehydroascorbic acid transmembrane transporter activity | 8.09e-04 | 8 | 109 | 2 | GO:0033300 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.01e-03 | 81 | 109 | 4 | GO:0035254 | |
| GeneOntologyMolecularFunction | galactoside binding | 1.04e-03 | 9 | 109 | 2 | GO:0016936 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.56e-03 | 42 | 109 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | guanylate kinase activity | 1.57e-03 | 11 | 109 | 2 | GO:0004385 | |
| GeneOntologyMolecularFunction | type I transforming growth factor beta receptor binding | 2.21e-03 | 13 | 109 | 2 | GO:0034713 | |
| GeneOntologyMolecularFunction | D-glucose binding | 2.57e-03 | 14 | 109 | 2 | GO:0005536 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF13B MYL3 ADGRV1 PFN2 KIFC2 SHANK3 RMDN3 GAS2L1 CTNNA3 PSG8 MYO18B FERMT2 KIF13A UNC13A | 2.61e-03 | 1099 | 109 | 14 | GO:0008092 |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 8.10e-12 | 11 | 108 | 6 | GO:0006171 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 2.03e-11 | 23 | 108 | 7 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 2.90e-09 | 44 | 108 | 7 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 2.93e-09 | 25 | 108 | 6 | GO:0046058 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 3.41e-09 | 45 | 108 | 7 | GO:0009187 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide biosynthetic process | ADCY4 GART ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 | 3.95e-07 | 232 | 108 | 10 | GO:0009152 |
| GeneOntologyBiologicalProcess | ribonucleotide biosynthetic process | ADCY4 GART ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 | 7.01e-07 | 247 | 108 | 10 | GO:0009260 |
| GeneOntologyBiologicalProcess | ribose phosphate biosynthetic process | ADCY4 GART ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 | 8.72e-07 | 253 | 108 | 10 | GO:0046390 |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | ADCY4 GART ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 | 2.18e-06 | 280 | 108 | 10 | GO:0006164 |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | ADCY4 GART ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 | 2.80e-06 | 288 | 108 | 10 | GO:0072522 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | MPP1 ADCY4 GART CLPX ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 AASS | 2.80e-06 | 512 | 108 | 13 | GO:0009150 |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | MPP1 ADCY4 GART CLPX ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 AASS | 4.34e-06 | 533 | 108 | 13 | GO:0009259 |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | MPP1 ADCY4 GART CLPX ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 AASS | 5.00e-06 | 540 | 108 | 13 | GO:0019693 |
| GeneOntologyBiologicalProcess | nucleotide biosynthetic process | ADCY4 GART ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 | 6.90e-06 | 319 | 108 | 10 | GO:0009165 |
| GeneOntologyBiologicalProcess | nucleoside phosphate biosynthetic process | ADCY4 GART ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 | 7.10e-06 | 320 | 108 | 10 | GO:1901293 |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | MPP1 ADCY4 GART SLC22A11 CLPX ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 AASS | 7.82e-06 | 652 | 108 | 14 | GO:0072521 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | MPP1 ADCY4 GNE GART CLPX ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 AASS PYCR3 | 1.10e-05 | 767 | 108 | 15 | GO:0055086 |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | MPP1 ADCY4 GART CLPX ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 AASS | 2.13e-05 | 619 | 108 | 13 | GO:0006163 |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | MPP1 ADCY4 GART CLPX ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 AASS | 5.97e-05 | 684 | 108 | 13 | GO:0009117 |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | MPP1 ADCY4 GNE GART CLPX ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A C1GALT1C1 GUCY1A2 GALNT11 AASS CLN6 PYCR3 | 6.43e-05 | 1226 | 108 | 18 | GO:1901135 |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | MPP1 ADCY4 GART CLPX ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 AASS | 6.61e-05 | 691 | 108 | 13 | GO:0006753 |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 1.08e-04 | 18 | 108 | 3 | GO:1904322 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | ADCY4 GNE GART ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A C1GALT1C1 GUCY1A2 GALNT11 | 1.24e-04 | 736 | 108 | 13 | GO:1901137 |
| GeneOntologyBiologicalProcess | response to forskolin | 1.27e-04 | 19 | 108 | 3 | GO:1904321 | |
| GeneOntologyBiologicalProcess | cell junction organization | SHANK1 MPDZ TSC2 PFN2 SHISA7 SHANK3 TGFB1 DIP2A SHANK2 ANAPC2 LRP5 PSG8 FERMT2 UNC13A MPP7 | 1.67e-04 | 974 | 108 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.73e-04 | 21 | 108 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.73e-04 | 21 | 108 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 2.59e-04 | 59 | 108 | 4 | GO:0045761 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 2.61e-04 | 24 | 108 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | positive regulation of glutamate receptor signaling pathway | 2.69e-04 | 5 | 108 | 2 | GO:1900451 | |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 2.95e-04 | 25 | 108 | 3 | GO:2000311 | |
| GeneOntologyBiologicalProcess | dendrite development | 3.83e-04 | 335 | 108 | 8 | GO:0016358 | |
| GeneOntologyBiologicalProcess | memory | 4.07e-04 | 183 | 108 | 6 | GO:0007613 | |
| GeneOntologyBiologicalProcess | regulation of receptor clustering | 4.62e-04 | 29 | 108 | 3 | GO:1903909 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 4.73e-04 | 69 | 108 | 4 | GO:0031279 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 5.10e-04 | 191 | 108 | 6 | GO:0007189 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte cytokine production | 5.56e-04 | 72 | 108 | 4 | GO:0061082 | |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | ADCY4 GART ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 DIP2A GUCY1A2 PLCG2 | 5.61e-04 | 644 | 108 | 11 | GO:0090407 |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 5.86e-04 | 73 | 108 | 4 | GO:0051339 | |
| GeneOntologyBiologicalProcess | social behavior | 6.17e-04 | 74 | 108 | 4 | GO:0035176 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 6.83e-04 | 76 | 108 | 4 | GO:0051703 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic potentiation | 7.42e-04 | 34 | 108 | 3 | GO:1900273 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 7.42e-04 | 34 | 108 | 3 | GO:0007190 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal stem cell proliferation | 7.45e-04 | 8 | 108 | 2 | GO:1902462 | |
| GeneOntologyBiologicalProcess | regulation of glutamate receptor signaling pathway | 7.45e-04 | 8 | 108 | 2 | GO:1900449 | |
| GeneOntologyCellularComponent | adherens junction | 1.24e-04 | 212 | 109 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SHANK1 SLC2A14 MPDZ TSC2 PFN2 ADCY1 SHISA7 SHANK3 SLC2A3 PPM1H DIP2A SHANK2 UNC13A | 3.31e-04 | 817 | 109 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | myosin II complex | 4.11e-04 | 28 | 109 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | cell projection membrane | 4.29e-04 | 431 | 109 | 9 | GO:0031253 | |
| MousePheno | increased anxiety-related response | SHANK1 SLC2A14 SHANK3 SLC2A3 SLC12A5 TARDBP SHANK2 LRP5 KIF13A FKBP5 | 1.65e-05 | 311 | 84 | 10 | MP:0001363 |
| Domain | A/G_cyclase_CS | 3.29e-12 | 17 | 108 | 7 | IPR018297 | |
| Domain | - | 5.36e-12 | 18 | 108 | 7 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 5.36e-12 | 18 | 108 | 7 | IPR029787 | |
| Domain | Guanylate_cyc | 8.45e-12 | 19 | 108 | 7 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 8.45e-12 | 19 | 108 | 7 | PS50125 | |
| Domain | A/G_cyclase | 8.45e-12 | 19 | 108 | 7 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 8.45e-12 | 19 | 108 | 7 | PS00452 | |
| Domain | CYCc | 8.45e-12 | 19 | 108 | 7 | SM00044 | |
| Domain | AC_N | 3.25e-10 | 8 | 108 | 5 | IPR032628 | |
| Domain | Adcy | 3.25e-10 | 8 | 108 | 5 | IPR030672 | |
| Domain | AC_N | 3.25e-10 | 8 | 108 | 5 | PF16214 | |
| Domain | SH3_2 | 1.64e-09 | 86 | 108 | 9 | PF07653 | |
| Domain | SH3_2 | 1.64e-09 | 86 | 108 | 9 | IPR011511 | |
| Domain | Adcy_conserved_dom | 1.57e-08 | 6 | 108 | 4 | IPR009398 | |
| Domain | DUF1053 | 1.57e-08 | 6 | 108 | 4 | PF06327 | |
| Domain | SH3 | 5.02e-07 | 216 | 108 | 10 | SM00326 | |
| Domain | SH3 | 5.02e-07 | 216 | 108 | 10 | PS50002 | |
| Domain | SH3_domain | 5.93e-07 | 220 | 108 | 10 | IPR001452 | |
| Domain | L27 | 7.26e-07 | 13 | 108 | 4 | SM00569 | |
| Domain | L27 | 7.26e-07 | 13 | 108 | 4 | PS51022 | |
| Domain | L27_dom | 7.26e-07 | 13 | 108 | 4 | IPR004172 | |
| Domain | PDZ | 1.61e-06 | 141 | 108 | 8 | PF00595 | |
| Domain | Guanylate_kinase_CS | 1.82e-06 | 16 | 108 | 4 | IPR020590 | |
| Domain | PDZ | 2.32e-06 | 148 | 108 | 8 | SM00228 | |
| Domain | - | 2.56e-06 | 150 | 108 | 8 | 2.30.42.10 | |
| Domain | PDZ | 2.70e-06 | 151 | 108 | 8 | PS50106 | |
| Domain | PDZ | 2.83e-06 | 152 | 108 | 8 | IPR001478 | |
| Domain | GUANYLATE_KINASE_2 | 8.60e-06 | 23 | 108 | 4 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 8.60e-06 | 23 | 108 | 4 | PS00856 | |
| Domain | Guanylate_kin | 1.43e-05 | 26 | 108 | 4 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 1.43e-05 | 26 | 108 | 4 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 1.43e-05 | 26 | 108 | 4 | IPR008144 | |
| Domain | GuKc | 1.43e-05 | 26 | 108 | 4 | SM00072 | |
| Domain | L27_C | 2.19e-05 | 10 | 108 | 3 | IPR014775 | |
| Domain | L27 | 2.19e-05 | 10 | 108 | 3 | PF02828 | |
| Domain | Glc_transpt_3 | 3.31e-05 | 2 | 108 | 2 | IPR002945 | |
| Domain | Kinesin-like_KIF1-typ | 1.97e-04 | 4 | 108 | 2 | IPR022140 | |
| Domain | KIF1B | 1.97e-04 | 4 | 108 | 2 | PF12423 | |
| Domain | FERM_f0 | 1.97e-04 | 4 | 108 | 2 | PF16511 | |
| Domain | Oxidoreductase_N | 1.97e-04 | 4 | 108 | 2 | IPR000683 | |
| Domain | GFO_IDH_MocA | 1.97e-04 | 4 | 108 | 2 | PF01408 | |
| Domain | FERM_f0 | 1.97e-04 | 4 | 108 | 2 | IPR032425 | |
| Domain | P-loop_NTPase | MPP1 MPP3 KIF13B DNAH10 CLPX NUBPL HELQ KIFC2 DDX1 MYO18B PALS2 KIF13A DDX28 MPP7 | 3.76e-04 | 848 | 108 | 14 | IPR027417 |
| Domain | Kinesin_assoc | 4.89e-04 | 6 | 108 | 2 | PF16183 | |
| Domain | Kinesin-like | 4.89e-04 | 6 | 108 | 2 | IPR022164 | |
| Domain | Kinesin_assoc | 4.89e-04 | 6 | 108 | 2 | IPR032405 | |
| Domain | DUF3694 | 4.89e-04 | 6 | 108 | 2 | PF12473 | |
| Domain | MFS_sugar_transport-like | 1.17e-03 | 36 | 108 | 3 | IPR005828 | |
| Domain | Sugar_tr | 1.17e-03 | 36 | 108 | 3 | PF00083 | |
| Domain | Kinesin_motor_CS | 1.71e-03 | 41 | 108 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.96e-03 | 43 | 108 | 3 | IPR027640 | |
| Domain | - | 2.10e-03 | 44 | 108 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 2.10e-03 | 44 | 108 | 3 | PF00225 | |
| Domain | KISc | 2.10e-03 | 44 | 108 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 2.10e-03 | 44 | 108 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 2.10e-03 | 44 | 108 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.10e-03 | 44 | 108 | 3 | PS50067 | |
| Domain | Sugar/inositol_transpt | 2.88e-03 | 14 | 108 | 2 | IPR003663 | |
| Domain | - | 3.01e-03 | 169 | 108 | 5 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 3.33e-03 | 173 | 108 | 5 | IPR016040 | |
| Domain | SUGAR_TRANSPORT_2 | 4.26e-03 | 17 | 108 | 2 | PS00217 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 8.27e-12 | 10 | 85 | 6 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 8.27e-12 | 10 | 85 | 6 | MM14668 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.16e-10 | 14 | 85 | 6 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.16e-10 | 14 | 85 | 6 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.93e-10 | 15 | 85 | 6 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 1.93e-10 | 15 | 85 | 6 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 1.93e-10 | 15 | 85 | 6 | M47504 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 3.07e-10 | 16 | 85 | 6 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 3.07e-10 | 16 | 85 | 6 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.07e-10 | 16 | 85 | 6 | MM14492 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 3.07e-10 | 16 | 85 | 6 | M39849 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 4.71e-10 | 17 | 85 | 6 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 4.71e-10 | 17 | 85 | 6 | M47544 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.46e-09 | 20 | 85 | 6 | M759 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 4.96e-09 | 24 | 85 | 6 | M47520 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 8.40e-09 | 26 | 85 | 6 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 8.40e-09 | 26 | 85 | 6 | MM14495 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 9.97e-09 | 46 | 85 | 7 | M39828 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.07e-08 | 27 | 85 | 6 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.07e-08 | 27 | 85 | 6 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 1.36e-08 | 28 | 85 | 6 | M47647 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 1.71e-08 | 29 | 85 | 6 | M47627 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.71e-08 | 29 | 85 | 6 | M47515 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.62e-08 | 31 | 85 | 6 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 3.21e-08 | 32 | 85 | 6 | M47506 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 3.62e-08 | 55 | 85 | 7 | M39763 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 3.91e-08 | 33 | 85 | 6 | MM15058 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 3.91e-08 | 33 | 85 | 6 | M11575 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 5.67e-08 | 35 | 85 | 6 | M47969 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 6.48e-08 | 90 | 85 | 8 | M835 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 8.04e-08 | 37 | 85 | 6 | M749 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.12e-07 | 39 | 85 | 6 | MM14496 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.53e-07 | 41 | 85 | 6 | M512 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 2.05e-07 | 43 | 85 | 6 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 2.05e-07 | 43 | 85 | 6 | M933 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.05e-07 | 43 | 85 | 6 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.36e-07 | 44 | 85 | 6 | MM15709 | |
| Pathway | REACTOME_GPER1_SIGNALING | 2.71e-07 | 45 | 85 | 6 | M45008 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 3.83e-07 | 113 | 85 | 8 | M16817 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 4.03e-07 | 48 | 85 | 6 | M10775 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 4.38e-07 | 115 | 85 | 8 | M9387 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 6.55e-07 | 52 | 85 | 6 | M920 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 7.61e-07 | 85 | 85 | 7 | M3578 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 8.23e-07 | 54 | 85 | 6 | M26911 | |
| Pathway | KEGG_GAP_JUNCTION | 1.12e-06 | 90 | 85 | 7 | M4013 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 1.55e-06 | 60 | 85 | 6 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 1.55e-06 | 60 | 85 | 6 | M976 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 1.62e-06 | 95 | 85 | 7 | M29842 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 2.07e-06 | 63 | 85 | 6 | M8 | |
| Pathway | KEGG_MELANOGENESIS | 2.45e-06 | 101 | 85 | 7 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.45e-06 | 101 | 85 | 7 | M1979 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 2.50e-06 | 65 | 85 | 6 | M15 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 3.19e-06 | 105 | 85 | 7 | MM15206 | |
| Pathway | WP_THERMOGENESIS | 3.85e-06 | 108 | 85 | 7 | M39746 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 4.21e-06 | 71 | 85 | 6 | MM14491 | |
| Pathway | KEGG_PURINE_METABOLISM | 5.06e-06 | 159 | 85 | 8 | M14314 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 5.20e-06 | 113 | 85 | 7 | M27471 | |
| Pathway | WP_PURINE_METABOLISM | 8.66e-06 | 171 | 85 | 8 | MM15909 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 1.60e-05 | 134 | 85 | 7 | M29840 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.67e-05 | 90 | 85 | 6 | M6467 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 1.67e-05 | 90 | 85 | 6 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 1.78e-05 | 91 | 85 | 6 | M39426 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.84e-05 | 137 | 85 | 7 | MM15182 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 3.31e-05 | 150 | 85 | 7 | M27440 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.92e-05 | 154 | 85 | 7 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 4.26e-05 | 156 | 85 | 7 | M39475 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 4.71e-05 | 108 | 85 | 6 | M17034 | |
| Pathway | WP_CANCER_PATHWAYS | ADCY4 KEAP1 CALML5 ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 TGFB1 CTNNA3 LRP5 PLCG2 | 4.96e-05 | 507 | 85 | 12 | M48302 |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 5.15e-05 | 219 | 85 | 8 | M29836 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.37e-04 | 252 | 85 | 8 | MM15585 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.31e-04 | 144 | 85 | 6 | MM14501 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.58e-04 | 147 | 85 | 6 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.98e-04 | 151 | 85 | 6 | M39329 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 3.67e-04 | 157 | 85 | 6 | M4904 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ADCY4 SLC39A2 SLC22A11 PSMB3 SLC2A14 ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 SLC2A3 SLC12A5 ATP12A | 4.38e-04 | 736 | 85 | 13 | M27287 |
| Pathway | WP_CHEMOKINE_SIGNALING | 4.79e-04 | 165 | 85 | 6 | M39400 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 5.90e-04 | 313 | 85 | 8 | M27867 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 7.14e-04 | 178 | 85 | 6 | M2890 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 8.49e-04 | 184 | 85 | 6 | MM15943 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 9.18e-04 | 335 | 85 | 8 | MM14503 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 9.49e-04 | 188 | 85 | 6 | M4844 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 1.26e-03 | 9 | 85 | 2 | MM14769 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.48e-03 | 205 | 85 | 6 | M752 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 1.57e-03 | 10 | 85 | 2 | M47648 | |
| Pathway | WP_NRF2_PATHWAY | 1.61e-03 | 141 | 85 | 5 | M39454 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.72e-03 | 211 | 85 | 6 | MM14502 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.28e-03 | 12 | 85 | 2 | MM1526 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 3.31e-03 | 411 | 85 | 8 | M735 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 3.59e-03 | 15 | 85 | 2 | M22002 | |
| Pubmed | 2.91e-14 | 16 | 110 | 7 | 17567809 | ||
| Pubmed | 7.27e-14 | 9 | 110 | 6 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 7.27e-14 | 9 | 110 | 6 | 17229090 | |
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 1.81e-13 | 10 | 110 | 6 | 11884542 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 1.81e-13 | 10 | 110 | 6 | 8663304 | |
| Pubmed | 1.81e-13 | 10 | 110 | 6 | 16615126 | ||
| Pubmed | 3.98e-13 | 11 | 110 | 6 | 10089566 | ||
| Pubmed | 3.98e-13 | 11 | 110 | 6 | 10808179 | ||
| Pubmed | 7.93e-13 | 12 | 110 | 6 | 10807185 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 2.56e-12 | 14 | 110 | 6 | 14993377 | |
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 3.60e-11 | 9 | 110 | 5 | 9417641 | |
| Pubmed | High-throughput microarray detection of olfactory receptor gene expression in the mouse. | 9.47e-11 | 4 | 110 | 4 | 15377787 | |
| Pubmed | 1.31e-10 | 11 | 110 | 5 | 11299302 | ||
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 2.25e-10 | 12 | 110 | 5 | 9611134 | |
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 8.45e-10 | 15 | 110 | 5 | 2165385 | |
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 1.41e-09 | 6 | 110 | 4 | 7766992 | |
| Pubmed | Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. | 1.41e-09 | 6 | 110 | 4 | 11549699 | |
| Pubmed | 3.29e-09 | 7 | 110 | 4 | 12613887 | ||
| Pubmed | Translational neurobiology in Shank mutant mice--model systems for neuropsychiatric disorders. | 3.08e-08 | 3 | 110 | 3 | 25917711 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 10806096 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 23583105 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 32564287 | ||
| Pubmed | 4.59e-08 | 31 | 110 | 5 | 12626323 | ||
| Pubmed | Ascorbic acid is a regulator of the intracellular cAMP concentration: old molecule, new functions? | 1.23e-07 | 4 | 110 | 3 | 18835269 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 23897824 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 12626503 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 16606358 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 21228062 | ||
| Pubmed | The insulin receptor substrate IRSp53 links postsynaptic shank1 to the small G-protein cdc42. | 3.06e-07 | 5 | 110 | 3 | 12504591 | |
| Pubmed | Mammalian adenylyl cyclase family members are randomly located on different chromosomes. | 3.06e-07 | 5 | 110 | 3 | 7959689 | |
| Pubmed | SHANK1 KIF13B HECTD4 MPDZ TSC2 KEAP1 PFN2 SHISA7 SHANK3 PPM1H KHSRP SLC12A5 SHANK2 NEURL4 UNC13A | 3.93e-07 | 963 | 110 | 15 | 28671696 | |
| Pubmed | SHANK1 ADCY4 PSMB3 ETFB SLC2A14 PFN2 SHANK3 SLC2A3 DDX1 KHSRP SLC12A5 GAS2L1 DIP2A SHANK2 GUCY1A2 ITSN2 FERMT2 UNC13A | 5.64e-07 | 1431 | 110 | 18 | 37142655 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ACADVL PSMB3 ETFB UFL1 TSC2 CLPX NUBPL ADCY9 BLVRA RMDN3 DIP2A AARS2 AASS ITSN2 CLN6 MRPL11 NEURL4 DDX28 | 1.07e-06 | 1496 | 110 | 18 | 32877691 |
| Pubmed | Direct interaction of GluRdelta2 with Shank scaffold proteins in cerebellar Purkinje cells. | 1.07e-06 | 7 | 110 | 3 | 15207857 | |
| Pubmed | The G protein-coupled receptor CL1 interacts directly with proteins of the Shank family. | 1.70e-06 | 8 | 110 | 3 | 10958799 | |
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 30319350 | ||
| Pubmed | MPP1 ETFB UFL1 NUBPL BLVRA RMDN3 AARS2 AASS CLN6 ZNHIT2 PYCR3 DDX28 | 1.91e-06 | 686 | 110 | 12 | 28380382 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 MPP3 HECTD4 TSC2 NUBPL KIFC2 ADCY7 ADCY9 GGT7 GAS2L1 DIP2A SHANK2 LRP5 MAPKBP1 ANKRD33B | 2.17e-06 | 1105 | 110 | 15 | 35748872 |
| Pubmed | 4.99e-06 | 11 | 110 | 3 | 26403076 | ||
| Pubmed | 7.31e-06 | 84 | 110 | 5 | 15123239 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 8.60e-06 | 13 | 110 | 3 | 27050589 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 33374598 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23615220 | ||
| Pubmed | Structure and mechanism of bactericidal mammalian perforin-2, an ancient agent of innate immunity. | 9.91e-06 | 2 | 110 | 2 | 32064340 | |
| Pubmed | Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice. | 9.91e-06 | 2 | 110 | 2 | 33402706 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 33126897 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 31009605 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25892112 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 33368883 | ||
| Pubmed | Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice. | 9.91e-06 | 2 | 110 | 2 | 18780771 | |
| Pubmed | Expression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain. | 9.91e-06 | 2 | 110 | 2 | 1734877 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 31884568 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 17068292 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23193055 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 31162142 | ||
| Pubmed | Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. | 9.91e-06 | 2 | 110 | 2 | 22699619 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 8198523 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20431059 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 31052177 | ||
| Pubmed | Altered lactate metabolism in Huntington's disease is dependent on GLUT3 expression. | 9.91e-06 | 2 | 110 | 2 | 29582588 | |
| Pubmed | Selective Localization of Shanks to VGLUT1-Positive Excitatory Synapses in the Mouse Hippocampus. | 9.91e-06 | 2 | 110 | 2 | 27199660 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22700768 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18445753 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 28324109 | ||
| Pubmed | Expression of the brain-type glucose transporter is restricted to brain and neuronal cells in mice. | 9.91e-06 | 2 | 110 | 2 | 1516757 | |
| Pubmed | Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation. | 9.91e-06 | 2 | 110 | 2 | 28663252 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10506216 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19506559 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23609114 | ||
| Pubmed | Adenylyl cyclase type 5 protein expression during cardiac development and stress. | 9.91e-06 | 2 | 110 | 2 | 19734365 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 8654954 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 33857757 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 33482226 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25188300 | ||
| Pubmed | Expression profiles of the autism-related SHANK proteins in the human brain. | 9.91e-06 | 2 | 110 | 2 | 37953224 | |
| Pubmed | TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. | 9.91e-06 | 2 | 110 | 2 | 35197626 | |
| Pubmed | TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. | 9.91e-06 | 2 | 110 | 2 | 35197628 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 36100669 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20800661 | ||
| Pubmed | Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain. | 9.91e-06 | 2 | 110 | 2 | 31817208 | |
| Pubmed | Brain glucose transporter (Glut3) haploinsufficiency does not impair mouse brain glucose uptake. | 9.91e-06 | 2 | 110 | 2 | 21316350 | |
| Pubmed | Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6. | 9.91e-06 | 2 | 110 | 2 | 21282557 | |
| Pubmed | SHANK3 in vagal sensory neurons regulates body temperature, systemic inflammation, and sepsis. | 9.91e-06 | 2 | 110 | 2 | 36845137 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10481931 | ||
| Pubmed | DEAD box protein DDX1 regulates cytoplasmic localization of KSRP. | 9.91e-06 | 2 | 110 | 2 | 24023901 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | GART PSMB3 ETFB TSC2 KEAP1 OSGEP CLPX PFN2 DDX1 KHSRP TARDBP COQ8A AASS QPCT FKBP5 | 1.02e-05 | 1257 | 110 | 15 | 37317656 |
| Pubmed | 1.05e-05 | 329 | 110 | 8 | 17474147 | ||
| Pubmed | 1.09e-05 | 14 | 110 | 3 | 21795692 | ||
| Pubmed | 1.11e-05 | 438 | 110 | 9 | 32628020 | ||
| Pubmed | HLA-DPB1 PSMB3 UFL1 TSC2 CLPX CALML5 NUBPL DDX1 KHSRP BLVRA AARS2 COQ8A AASS HCFC2 MRPL11 FKBP5 | 1.22e-05 | 1440 | 110 | 16 | 30833792 | |
| Pubmed | 1.36e-05 | 15 | 110 | 3 | 7937899 | ||
| Pubmed | 1.36e-05 | 15 | 110 | 3 | 34835087 | ||
| Pubmed | 1.75e-05 | 464 | 110 | 9 | 32457219 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MPP1 ACADVL GART ETFB UFL1 KEAP1 CLPX DDX1 KHSRP BLVRA TARDBP NFRKB CLN6 PYCR3 FKBP5 | 1.78e-05 | 1318 | 110 | 15 | 30463901 |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 25578782 | ||
| Pubmed | Site-1 protease inhibits mitochondrial respiration by controlling the TGF-β target gene Mss51. | 2.97e-05 | 3 | 110 | 2 | 37002920 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 11583995 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 28345660 | ||
| Pubmed | Glucose transporter GLUT3: ontogeny, targeting, and role in the mouse blastocyst. | 2.97e-05 | 3 | 110 | 2 | 9108057 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 38395965 | ||
| Interaction | GUCY1B1 interactions | 1.10e-10 | 47 | 105 | 8 | int:GUCY1B1 | |
| Interaction | LIN7A interactions | 6.24e-07 | 59 | 105 | 6 | int:LIN7A | |
| Cytoband | 1q44 | 7.22e-06 | 110 | 110 | 5 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 1.51e-05 | 128 | 110 | 5 | chr1q44 | |
| Cytoband | 15q22.31 | 1.44e-04 | 42 | 110 | 3 | 15q22.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 8.15e-04 | 454 | 110 | 6 | chr11q13 | |
| Cytoband | 3q21.1 | 1.05e-03 | 20 | 110 | 2 | 3q21.1 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.28e-12 | 10 | 80 | 6 | 53 | |
| GeneFamily | PDZ domain containing | 3.60e-07 | 152 | 80 | 8 | 1220 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 4.93e-06 | 26 | 80 | 4 | 904 | |
| GeneFamily | Olfactory receptors, family 2 | 1.44e-04 | 113 | 80 | 5 | 149 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.10e-03 | 46 | 80 | 3 | 622 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 1.70e-03 | 14 | 80 | 2 | 657 | |
| GeneFamily | Ankyrin repeat domain containing | 4.39e-03 | 242 | 80 | 5 | 403 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 147 | 110 | 6 | f5109e0f4e8b46a977a763c9c72a2df9840e3977 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 147 | 110 | 6 | ad0c575bc9c5f201f2a7810452e8b3f741e65d89 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 161 | 110 | 6 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | 15-Trachea-Immune-Hematopoietic,_B_Cells|Trachea / Age, Tissue, Lineage and Cell class | 6.10e-06 | 182 | 110 | 6 | 1424d990598d37b22fa44df032be97c1cd1363d1 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.29e-06 | 183 | 110 | 6 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.49e-06 | 184 | 110 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.70e-06 | 185 | 110 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.34e-06 | 188 | 110 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.34e-06 | 188 | 110 | 6 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.57e-06 | 189 | 110 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.80e-06 | 190 | 110 | 6 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.28e-06 | 192 | 110 | 6 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.28e-06 | 192 | 110 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.28e-06 | 192 | 110 | 6 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.78e-06 | 194 | 110 | 6 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 3.23e-05 | 147 | 110 | 5 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.27e-05 | 169 | 110 | 5 | c3d410a5e98000ba872141b62e17ef4ed3d1a8eb | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.27e-05 | 169 | 110 | 5 | c6e5b179461996ced6c7621dc01cec00d401f4e8 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 171 | 110 | 5 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 172 | 110 | 5 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 6.82e-05 | 172 | 110 | 5 | 9dca1542145d88559527db7e0f6ad150df59ca2d | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 172 | 110 | 5 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 173 | 110 | 5 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-05 | 173 | 110 | 5 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 173 | 110 | 5 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.20e-05 | 174 | 110 | 5 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 7.60e-05 | 176 | 110 | 5 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | IIH-mDC1-|IIH / Condition, Cell_class and T cell subcluster | 7.60e-05 | 176 | 110 | 5 | bb80a3e595d071f6cc8b042984b8d9490e377eef | |
| ToppCell | IIH-mDC1|IIH / Condition, Cell_class and T cell subcluster | 7.60e-05 | 176 | 110 | 5 | a75dc132a1061006fd1cb305bd314784fca07ea6 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.81e-05 | 177 | 110 | 5 | d4db058c09012ec9fbde61277a9f86d9956de8fc | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-05 | 178 | 110 | 5 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.02e-05 | 178 | 110 | 5 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-05 | 180 | 110 | 5 | d76349ecef7c5878bf215e946f032264161eb61b | |
| ToppCell | wk_08-11-Hematologic-Myeloid-pre-pDC/DC5|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.90e-05 | 182 | 110 | 5 | fec8a2d6d4099722b8e1bb41222108ed74268fcf | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 9.13e-05 | 183 | 110 | 5 | 6c55fd737ed31f5b1aa41dc4dba7240521c19022 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-05 | 184 | 110 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.37e-05 | 184 | 110 | 5 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 9.61e-05 | 185 | 110 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-05 | 185 | 110 | 5 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 9.61e-05 | 185 | 110 | 5 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | (5)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.86e-05 | 186 | 110 | 5 | acbca8cc048d87faf859b3e77bdb38d0a3dad71c | |
| ToppCell | (5)_Pericytes-(50)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.86e-05 | 186 | 110 | 5 | 67b59defdd1ed3608229cc5e2a3b480d92312afa | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-05 | 186 | 110 | 5 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue | 1.01e-04 | 187 | 110 | 5 | 9f3db9f0e5de34aeabfe5984f675bc7a65435df7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 187 | 110 | 5 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 187 | 110 | 5 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 187 | 110 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 187 | 110 | 5 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.01e-04 | 187 | 110 | 5 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 187 | 110 | 5 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 110 | 5 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 188 | 110 | 5 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.04e-04 | 188 | 110 | 5 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 110 | 5 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 110 | 5 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.04e-04 | 188 | 110 | 5 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 189 | 110 | 5 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 189 | 110 | 5 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 189 | 110 | 5 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.09e-04 | 190 | 110 | 5 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.09e-04 | 190 | 110 | 5 | 7ba2be2630183df86de21689289a8620a4cd507e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-04 | 191 | 110 | 5 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.12e-04 | 191 | 110 | 5 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 110 | 5 | 45023854f285ac465f23ea1b33c970e14992e709 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 110 | 5 | 6890a8e4b4530987a5b044614fcd7e00716a4d66 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 110 | 5 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_B_Cells|Trachea / Age, Tissue, Lineage and Cell class | 1.12e-04 | 191 | 110 | 5 | 5e49fca1247713b51c4980480350fe5891d40d4a | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 110 | 5 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 110 | 5 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 192 | 110 | 5 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 192 | 110 | 5 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 110 | 5 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 194 | 110 | 5 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 195 | 110 | 5 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 195 | 110 | 5 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-04 | 197 | 110 | 5 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | Biopsy_IPF-Immune-B_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.32e-04 | 198 | 110 | 5 | 6a519337a4932a7b685fe7defd3de24fa2016b7d | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.32e-04 | 198 | 110 | 5 | c79c1738560d78b63dbed5f2f9621dbc1c2363cb | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.32e-04 | 198 | 110 | 5 | 1d1c80569f1e307285ba0ebaf5c72e0b5b538864 | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-04 | 198 | 110 | 5 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | dc8702e3cb4ac8c1a9849fc8abf8777f12d55b0b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R---L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | d92d51021ab6d78e9c8f89f7c150181004dcbcbd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-04 | 200 | 110 | 5 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | cbbb9044283ff9ab63bbfc24d7a9f006b1372705 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 200 | 110 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-04 | 200 | 110 | 5 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | a3e36bbeed19431d07bc205f14f4e0f12bd8f730 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 200 | 110 | 5 | 4f7be296be0cd54cfc62cc93263fde26210c61f4 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 200 | 110 | 5 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.38e-04 | 200 | 110 | 5 | ad0d38ffe5ca138b40823d15b239c2f9f3f0e93c | |
| Drug | AC1L1EV8 | 2.75e-13 | 8 | 108 | 6 | CID000002964 | |
| Drug | 14,15-dihydroforskolin | 8.22e-13 | 9 | 108 | 6 | CID000194193 | |
| Drug | 2',5'-dd3'-FSBA | 2.05e-12 | 10 | 108 | 6 | CID003081206 | |
| Drug | NC-5Z | 2.05e-12 | 10 | 108 | 6 | CID003035914 | |
| Drug | AC1L40QM | 4.49e-12 | 11 | 108 | 6 | CID000099213 | |
| Drug | B-Mlvp | 4.49e-12 | 11 | 108 | 6 | CID000195648 | |
| Drug | AC1NY9KD | 4.49e-12 | 11 | 108 | 6 | CID005771741 | |
| Drug | FCE 23884 | 1.65e-11 | 13 | 108 | 6 | CID000065898 | |
| Drug | AC1L1BJN | 1.65e-11 | 13 | 108 | 6 | CID000001467 | |
| Drug | sclareol glycol | 1.65e-11 | 13 | 108 | 6 | CID000091915 | |
| Drug | nantradol hydrochloride | 1.65e-11 | 13 | 108 | 6 | CID000047652 | |
| Drug | SM-10906 | 3.64e-11 | 27 | 108 | 7 | CID006442261 | |
| Drug | SKF 75670 | 4.78e-11 | 15 | 108 | 6 | CID000173870 | |
| Drug | BMY 42393 | 4.78e-11 | 15 | 108 | 6 | CID000131961 | |
| Drug | AC1L2AAS | 4.78e-11 | 15 | 108 | 6 | CID000068714 | |
| Drug | tetrahydrofurfuryl alcohol | 4.84e-11 | 28 | 108 | 7 | CID000007360 | |
| Drug | San 21009 | 1.17e-10 | 17 | 108 | 6 | CID000152662 | |
| Drug | U754 | 1.17e-10 | 17 | 108 | 6 | CID000062824 | |
| Drug | fentanyl isothiocyanate | 1.17e-10 | 17 | 108 | 6 | CID000084008 | |
| Drug | Ro 41-9067 | 2.55e-10 | 19 | 108 | 6 | CID000125800 | |
| Drug | AC1L3XQA | 2.55e-10 | 19 | 108 | 6 | CID000124009 | |
| Drug | SK&F 82958 | 2.55e-10 | 19 | 108 | 6 | ctd:C071262 | |
| Drug | Dvdavp | 3.63e-10 | 20 | 108 | 6 | CID006441676 | |
| Drug | YM435 | 3.63e-10 | 20 | 108 | 6 | CID000132119 | |
| Drug | 6-fluoronorepinephrine | 5.07e-10 | 21 | 108 | 6 | CID000001862 | |
| Drug | reproterol | 5.07e-10 | 21 | 108 | 6 | CID000025654 | |
| Drug | 8-iso Misoprostol | 5.39e-10 | 62 | 108 | 8 | CID004183806 | |
| Drug | GSK835726 | 6.94e-10 | 22 | 108 | 6 | CID005311268 | |
| Drug | beta-CNA | 9.36e-10 | 23 | 108 | 6 | CID005486190 | |
| Drug | Scpb | 9.36e-10 | 23 | 108 | 6 | CID000123843 | |
| Drug | ethacrynic acid | KIF13B ADCY4 ADCY1 ADCY5 KIFC2 ADCY6 ADCY7 ADCY9 SLC12A5 KIF13A | 1.13e-09 | 138 | 108 | 10 | CID000003278 |
| Drug | NAIN | 1.24e-09 | 24 | 108 | 6 | CID000195228 | |
| Drug | TL-99 | 1.24e-09 | 24 | 108 | 6 | CID000122132 | |
| Drug | DEPX | 1.24e-09 | 24 | 108 | 6 | CID000001328 | |
| Drug | trimetoquinol | 1.24e-09 | 24 | 108 | 6 | CID000005581 | |
| Drug | AC1L8VEV | 1.24e-09 | 24 | 108 | 6 | CID000433433 | |
| Drug | AC1L9NB5 | 1.63e-09 | 25 | 108 | 6 | CID000449609 | |
| Drug | PD 81,723 | 1.63e-09 | 25 | 108 | 6 | CID000122028 | |
| Drug | tiotidine | 1.63e-09 | 25 | 108 | 6 | CID000050287 | |
| Drug | octimibate | 1.63e-09 | 25 | 108 | 6 | CID000065676 | |
| Drug | manganese-ATP | 1.63e-09 | 25 | 108 | 6 | CID000124341 | |
| Drug | N-n-propylnorapomorphine | 1.63e-09 | 25 | 108 | 6 | CID000030137 | |
| Drug | metaproterenol | 2.11e-09 | 26 | 108 | 6 | CID000004086 | |
| Drug | 7B-forskolin | 2.11e-09 | 26 | 108 | 6 | CID000130638 | |
| Drug | Lypressin | 2.39e-09 | 47 | 108 | 7 | CID000005772 | |
| Drug | RU 24926 | 2.70e-09 | 27 | 108 | 6 | CID000122203 | |
| Drug | prenalterol | 3.43e-09 | 28 | 108 | 6 | CID000042396 | |
| Drug | desacetylnantradol | 3.43e-09 | 28 | 108 | 6 | CID000125211 | |
| Drug | butoxamine | 3.43e-09 | 28 | 108 | 6 | CID000018026 | |
| Drug | Nocloprostum | 3.43e-09 | 28 | 108 | 6 | CID006435380 | |
| Drug | motapizone | 4.30e-09 | 29 | 108 | 6 | CID000065819 | |
| Drug | tolazoline | 4.30e-09 | 29 | 108 | 6 | CID000005504 | |
| Drug | etazolate | 4.30e-09 | 29 | 108 | 6 | CID000003277 | |
| Drug | NSC97113 | 4.33e-09 | 51 | 108 | 7 | CID000001869 | |
| Drug | AC1N2DGT | 5.36e-09 | 30 | 108 | 6 | CID004045015 | |
| Drug | dihydroalprenolol | 5.36e-09 | 30 | 108 | 6 | CID000043216 | |
| Drug | 4-hydroxynonenal | ADCY4 PSMB3 CASP1 TSC2 KEAP1 ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 SLC2A3 GGT7 TGFB1 NFRKB PLCG2 | 6.57e-09 | 471 | 108 | 15 | CID000001693 |
| Drug | zinterol | 6.62e-09 | 31 | 108 | 6 | CID000037989 | |
| Drug | AC1L3P1W | 6.62e-09 | 31 | 108 | 6 | CID000119574 | |
| Drug | probenecid | 7.28e-09 | 123 | 108 | 9 | CID000004911 | |
| Drug | RU 24969 | 8.12e-09 | 32 | 108 | 6 | CID000108028 | |
| Drug | dopexamine | 8.12e-09 | 32 | 108 | 6 | CID000055483 | |
| Drug | metiamide | 9.88e-09 | 33 | 108 | 6 | CID001548992 | |
| Drug | 6,7-ADTN | 9.88e-09 | 33 | 108 | 6 | CID000003153 | |
| Drug | phosphonate analog | 9.88e-09 | 33 | 108 | 6 | CID000475766 | |
| Drug | N6-monobutyryl-cAMP | 9.88e-09 | 33 | 108 | 6 | CID000115029 | |
| Drug | Depixol | 9.88e-09 | 33 | 108 | 6 | CID000017011 | |
| Drug | iodocyanopindolol | 9.88e-09 | 33 | 108 | 6 | CID000068618 | |
| Drug | 2,4-dinitrophenol | 1.11e-08 | 90 | 108 | 8 | CID000001493 | |
| Drug | AC1Q3G0K | 1.39e-08 | 60 | 108 | 7 | CID000002087 | |
| Drug | zardaverine | 1.44e-08 | 35 | 108 | 6 | CID000005723 | |
| Drug | 8-bromoadenosine | 1.45e-08 | 133 | 108 | 9 | CID000096544 | |
| Drug | iohexol | 1.57e-08 | 61 | 108 | 7 | CID000003730 | |
| Drug | quin2 | 1.70e-08 | 95 | 108 | 8 | CID000104841 | |
| Drug | AC1L1DSZ | 1.72e-08 | 36 | 108 | 6 | CID000002494 | |
| Drug | chlorthalidone | 1.72e-08 | 36 | 108 | 6 | CID000002732 | |
| Drug | enprofylline | 1.72e-08 | 36 | 108 | 6 | CID000001676 | |
| Drug | N-ethylmaleimide | KIF13B ADCY4 MYL1 MYL3 GART CASP1 CLPX ADCY1 ADCY5 KIFC2 ADCY6 ADCY7 ADCY9 MYO18B KIF13A | 1.94e-08 | 511 | 108 | 15 | CID000004362 |
| Drug | practolol | 2.04e-08 | 37 | 108 | 6 | CID000004883 | |
| Drug | eye gene | ADCY4 MYL1 MYL3 TSC2 ADCY1 ADCY5 ADCY6 ADCY7 ADCY9 IGDCC4 GUCY1A2 PLCG2 MYO18B | 2.22e-08 | 369 | 108 | 13 | CID000004782 |
| Drug | 2g6p | 2.42e-08 | 38 | 108 | 6 | CID002740174 | |
| Drug | AC1L1XPX | 2.42e-08 | 38 | 108 | 6 | CID000011606 | |
| Drug | clenbuterol | 2.56e-08 | 142 | 108 | 9 | CID000002783 | |
| Drug | MDL-12330A | 2.75e-08 | 66 | 108 | 7 | CID000004024 | |
| Drug | N6-cyclohexyladenosine | 3.33e-08 | 40 | 108 | 6 | CID000002692 | |
| Drug | Lopac-S-1316 | 3.33e-08 | 40 | 108 | 6 | CID003086457 | |
| Drug | dimaprit | 3.33e-08 | 40 | 108 | 6 | CID000003077 | |
| Drug | AC1NSKJI | 3.39e-08 | 68 | 108 | 7 | CID005311391 | |
| Drug | AC1NIP3C | 3.89e-08 | 41 | 108 | 6 | CID004834553 | |
| Drug | AC1L1I54 | 3.89e-08 | 41 | 108 | 6 | CID000004426 | |
| Drug | N6-(phenylisopropyl)adenosine | 3.89e-08 | 41 | 108 | 6 | CID000034507 | |
| Drug | DAR-0100A | 3.89e-08 | 41 | 108 | 6 | CID000060759 | |
| Drug | lead compounds | 4.13e-08 | 150 | 108 | 9 | CID000073212 | |
| Drug | fenoldopam | 4.16e-08 | 70 | 108 | 7 | CID000003340 | |
| Drug | BRL 37344 | 4.52e-08 | 42 | 108 | 6 | CID000002436 | |
| Drug | CGP 12177 | 4.52e-08 | 42 | 108 | 6 | CID000002687 | |
| Drug | sulprostone | 4.60e-08 | 71 | 108 | 7 | CID005312153 | |
| Drug | 4-isopropylaniline | 4.60e-08 | 71 | 108 | 7 | CID000007464 | |
| Drug | amrinone | 5.23e-08 | 43 | 108 | 6 | CID000003698 | |
| Drug | AC1L1E5T | 6.15e-08 | 74 | 108 | 7 | CID000002653 | |
| Disease | Neonatal disorder | 1.25e-05 | 2 | 105 | 2 | C0021290 | |
| Disease | Alzheimer's disease (is_marker_for) | 3.23e-04 | 257 | 105 | 6 | DOID:10652 (is_marker_for) | |
| Disease | Sarcoidosis | 3.46e-04 | 8 | 105 | 2 | C0036202 | |
| Disease | Developmental Coordination Disorder | 3.46e-04 | 8 | 105 | 2 | C0011757 | |
| Disease | Motor Skills Disorders | 3.46e-04 | 8 | 105 | 2 | C0026613 | |
| Disease | Disorder of fatty acid metabolism | 4.44e-04 | 9 | 105 | 2 | cv:C0268634 | |
| Disease | aplastic anemia (is_marker_for) | 4.44e-04 | 9 | 105 | 2 | DOID:12449 (is_marker_for) | |
| Disease | Hepatic Insufficiency | 4.44e-04 | 9 | 105 | 2 | C1306571 | |
| Disease | Berylliosis | 6.76e-04 | 11 | 105 | 2 | C0005138 | |
| Disease | Beryllium Disease | 6.76e-04 | 11 | 105 | 2 | C2350873 | |
| Disease | body mass index, fasting blood glucose measurement | 8.05e-04 | 51 | 105 | 3 | EFO_0004340, EFO_0004465 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 9.37e-04 | 315 | 105 | 6 | EFO_0004574, EFO_0004612 | |
| Disease | Small cell carcinoma of lung | 9.52e-04 | 54 | 105 | 3 | C0149925 | |
| Disease | cataract (biomarker_via_orthology) | 9.54e-04 | 13 | 105 | 2 | DOID:83 (biomarker_via_orthology) | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 9.54e-04 | 13 | 105 | 2 | C0369183 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 9.54e-04 | 13 | 105 | 2 | C1261502 | |
| Disease | Inflammation | 1.12e-03 | 127 | 105 | 4 | C0021368 | |
| Disease | urate measurement | DOCK3 SLC22A11 HECTD4 SLC25A30 ADGRV1 DDX1 SHANK2 COQ8A MYO18B PALS2 | 1.35e-03 | 895 | 105 | 10 | EFO_0004531 |
| Disease | Post-Traumatic Osteoporosis | 1.36e-03 | 61 | 105 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 1.36e-03 | 61 | 105 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 1.36e-03 | 61 | 105 | 3 | C0001787 | |
| Disease | Urticaria | 1.46e-03 | 16 | 105 | 2 | C0042109 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 1.46e-03 | 16 | 105 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | Osteoporosis | 1.49e-03 | 63 | 105 | 3 | C0029456 | |
| Disease | opioid dependence | 1.61e-03 | 237 | 105 | 5 | EFO_0005611 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.78e-03 | 67 | 105 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | Nonorganic psychosis | 1.93e-03 | 69 | 105 | 3 | C0349204 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.16e-03 | 152 | 105 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | osteoporosis (biomarker_via_orthology) | 2.77e-03 | 22 | 105 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | lung disease (is_implicated_in) | 2.77e-03 | 22 | 105 | 2 | DOID:850 (is_implicated_in) | |
| Disease | Asthma | 2.95e-03 | 80 | 105 | 3 | C0004096 | |
| Disease | Mood Disorders | 3.10e-03 | 168 | 105 | 4 | C0525045 | |
| Disease | Epilepsy, Cryptogenic | 3.16e-03 | 82 | 105 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.16e-03 | 82 | 105 | 3 | C0751111 | |
| Disease | Aura | 3.16e-03 | 82 | 105 | 3 | C0236018 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 3.29e-03 | 24 | 105 | 2 | DOID:1184 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRRIHMDDTGLTVLR | 1656 | Q9UPW8 | |
| LRRVAVTGGTHGNEM | 11 | Q96HD9 | |
| AQGLREEVHTMLRGV | 146 | Q9UJX6 | |
| RGISGGRIHMSVLGR | 26 | O76031 | |
| GRIHMSVLGRLGTFE | 31 | O76031 | |
| GVNVNMRVGIHSGRV | 466 | O43306 | |
| MRVGIHSGRVHCGVL | 471 | O43306 | |
| MLQVHRTGLGRLGVS | 1 | Q9UDR5 | |
| VELMIHRTGGSLGQV | 2606 | Q8WXG9 | |
| SGLELREGAVMRRLH | 5376 | Q8WXG9 | |
| GLIICGVGIFMHRRS | 236 | P04440 | |
| RAATGVDINMRVGVH | 356 | Q8NFM4 | |
| MRVGIHSGNVLCGVI | 371 | P51828 | |
| GVNVNMRVGIHSGRV | 556 | O95622 | |
| MRVGIHSGRVHCGVL | 561 | O95622 | |
| GHITVDELRRAMAGL | 96 | Q9NZT1 | |
| LITMLGHIRIGHGNR | 21 | Q96EU7 | |
| VRGPEDGGVLDHMVR | 296 | A6NCL7 | |
| VEDRAEVHSLMGGGV | 1036 | Q8TDY8 | |
| MAGGRHRRVVGTLHL | 1 | Q16769 | |
| SGIGRLMVHVIEATE | 1566 | Q9NZM3 | |
| IELRRAMNVIHGDGG | 636 | Q2M385 | |
| DRDAVSGMGVIVHII | 176 | P49720 | |
| GMEVDIHRSLLVTGI | 16 | Q86V59 | |
| ATVEIHLEGRCGGRM | 166 | Q13451 | |
| ELMHGVAGVTSRAGR | 21 | Q460N3 | |
| HRAVAIRELMIIFGG | 26 | Q9Y5Z7 | |
| HGTRIMEDCLLGGTR | 21 | Q6P4R8 | |
| PGHLGLRVVMVGVDV | 291 | Q4VC12 | |
| GTVMGAELRHVLATL | 146 | P08590 | |
| GMVINTGDRTIIGHI | 271 | P54707 | |
| HRLSGEAMGVVLRGD | 1051 | O75197 | |
| HRIGRVGRAERMGLA | 601 | Q92499 | |
| GNMDGRVRIHDLRSG | 451 | Q8N3Y1 | |
| RVIAIKVMARDGGGR | 2551 | Q9NYQ8 | |
| GGGVMLVHDIRRNES | 186 | Q9UJ14 | |
| VILAVIHMGSGEGRC | 221 | Q96R28 | |
| VILAVIHMGSGEGRR | 221 | Q8NG83 | |
| VLRAVIHMGSGESRR | 221 | Q96R27 | |
| VILAVIHMGSGEGRR | 221 | A3KFT3 | |
| VILAVIHMGSGEGRR | 221 | Q8NG81 | |
| KREGLIRGRMIGAAH | 221 | Q8NCW6 | |
| IRGRMIGAAHATGEV | 226 | Q8NCW6 | |
| RIMRGGAADRSGLIH | 166 | Q5T2T1 | |
| GLLVRDLEGGHGMRR | 231 | Q9NUL7 | |
| ITEALAQGGMHIRAR | 386 | Q96RN5 | |
| TVMGAELRHVLATLG | 146 | P05976 | |
| GRVQHCRIRSTMEGG | 581 | P16885 | |
| HMRELLTAAVRVGGV | 1201 | Q9Y4D8 | |
| VAMSGHRVGALDERG | 91 | Q9Y6Z4 | |
| IGHIEMGRLITGATS | 111 | Q9NPF4 | |
| ERAGRRTLHMIGLGG | 351 | Q8TDB8 | |
| RRRQGHIVVISSVMG | 131 | Q9NYR8 | |
| VAVGRAGRVLVFVMG | 101 | P35080 | |
| DLVIARILHGGMIDR | 151 | Q9NZW5 | |
| RILHGGMIDRQGLLH | 156 | Q9NZW5 | |
| RGRAARVAHIVTGEM | 541 | Q9UI47 | |
| VDLNMRVGLHTGRVL | 391 | Q08828 | |
| GMLHALVRIGREEGL | 51 | Q5SVS4 | |
| RHPTMGSVFIGRLIE | 341 | P29466 | |
| RIMDVLGRLRHVSGE | 621 | Q8IZD9 | |
| MNIRILHIEGGEVSG | 126 | Q9Y223 | |
| VRVLRSHVMVRVGGG | 246 | Q99501 | |
| VMVVGSAGRLVARGA | 251 | Q3B7J2 | |
| IGQVHLARMKGGREV | 341 | Q8NI60 | |
| MRVGVHTGTVLCGIL | 486 | O60503 | |
| VVVVGVGRAGSVRMR | 11 | P53004 | |
| LGFGSVLLMVRRGHV | 86 | Q8N5U1 | |
| GQHLASGDRMGTLRV | 491 | O60336 | |
| VERAGRRTLHMIGLG | 326 | P11169 | |
| HLVAPMLTRRIGVGV | 451 | Q14145 | |
| VARILHGGMIHRQGS | 96 | Q00013 | |
| GKLDGLMVTGVRRHN | 806 | Q14689 | |
| AVVFRVHLLLGGERM | 86 | Q49AJ0 | |
| VVDELHMIGEGSRGA | 461 | Q8TDG4 | |
| VTLRVTGEVHIGGVM | 31 | Q96AC1 | |
| IIRMDRGHALLVGVG | 2791 | Q8IVF4 | |
| RMTADGILHTVGRLG | 461 | Q9NSA0 | |
| GAGRQHRVTLSMVEI | 516 | Q96AC6 | |
| SRVGVRRGADDTMHI | 1036 | Q96JN8 | |
| GAEMFRRVHVPVLGL | 221 | Q8TB37 | |
| VLTEHLDRVMLVRGG | 1116 | Q9H2X9 | |
| LDRVMLVRGGGREVI | 1121 | Q9H2X9 | |
| IRIIIVILGMHSAEG | 246 | Q8NGW6 | |
| HSGAVVVARIMRGGA | 156 | Q13368 | |
| IQMRIGIHSGSVLAG | 611 | P33402 | |
| QGEVAGRLHVEVMRV | 816 | Q9H1H9 | |
| GRLHVEVMRVTGAVP | 821 | Q9H1H9 | |
| VGGVIRAIVRAGLAM | 16 | Q9Y3B7 | |
| RHSVGVVIGRSGEMI | 331 | Q92945 | |
| GRLHVEVMRLSGDVG | 831 | Q9NQT8 | |
| RGLAGEIVGEVRCHM | 116 | Q96TC7 | |
| VRLEGTVVHMLRGRA | 1071 | A2VEC9 | |
| TVVHMLRGRAVTVNG | 1076 | A2VEC9 | |
| MRGVRLVEGILHAPD | 51 | Q13148 | |
| TLHIIMGGDENRGVT | 121 | Q9UQ74 | |
| RTALAMGADRGIHVE | 76 | P38117 | |
| RRVMSQEHLLGDGGR | 381 | A6NL88 | |
| VQEGAIVMARGRHVG | 131 | Q53H96 | |
| QRHVDTGMGLERLVA | 261 | Q5JTZ9 | |
| AHKGLVVFGVGMRLV | 201 | Q9NP94 | |
| IDLGVTRVGHRMNIE | 1826 | Q9UPX8 | |
| GVTRVGHRMNIDRAL | 2141 | Q9Y566 | |
| ARLVEIVGMHDLGVG | 161 | P49748 | |
| GRGHMAVLQRLVDIG | 201 | Q495B1 | |
| MEATRRRQHLGATGG | 1 | Q9NWW5 | |
| AGCMLKSGRHRVGEV | 201 | A2A3L6 | |
| MIVRSIIHGGAISRD | 1031 | O75970 | |
| GVTRVGHRMNIERAL | 1711 | Q9BYB0 | |
| RVMATIGVTRGLGDH | 381 | Q9ULR3 | |
| TGRRGDLATIHGMNR | 241 | P01137 | |
| MAARVLIIGSGGREH | 1 | P22102 | |
| HLVGMAGSVDGRVSV | 676 | Q8IUG5 | |
| VEGVMRVIGGSNHLA | 336 | Q96K49 | |
| LGTRGAMHEVARILL | 281 | Q9UHR6 | |
| IGVTMVGIHARTGRE | 281 | Q99633 | |
| MRDELHVRGGRVNIV | 66 | O94874 | |
| DRVRSMSGGHGLRVG | 1126 | P49815 | |
| AHVSMAEVIGLLGGR | 591 | Q5VVJ2 |